TRDA

Entrada Therapeutics INC

+$70.0M

Net Activity

Institutions Holding

119

Popularity Rank

#4094

Avg Weight

0.20%

Total Value

$319.5M

Ownership Trend

119 institutions currently hold TRDA, with 62 net buyers and 47 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

47

Net Buying Institutions

62

Key Holders

View all 119 holding institutions

Quarterly Activity

Recent Activity

+$129.5M

Total Buy Value

$44.3M

Total Sell Value

New buy15
Trim33
Add47
Sold out14

62

Net Buyers

47

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding ENTRADA THERAPEUTICS INC (TRDA)?
Major stakeholders currently include Baker Bros. Advisors LP ($64.0M), 5AM Venture Management, LLC ($51.2M), BlackRock, Inc. ($29.8M). Based on the latest 13F filings, there are a total of 119 tracked investment funds and institutions maintaining positions in TRDA.
What is the overall institutional sentiment toward TRDA recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $70.0M, driven by 62 managers accumulating shares while 47 reduced their exposure.
Which institutions have been selling or reducing their TRDA positions?
In the latest period, 33 funds trimmed their holdings, and 14 managers completely exited their positions. The aggregate reported sell value was $44.3M.
Are there any notable investors adding TRDA to their portfolios?
Yes, buying activity remains notable. 15 institutions opened new positions in {ticker}, and 47 existing holders added to their shares. The total reported buy value for the quarter amounted to $129.5M.

Related Stocks